Investors

We maintain a transparent, comprehensive dialogue with the financial community about our strategy, outlook, financial data, economic environment, and social impact.

/assets/dotcom/content-app/events/banner-investors-events_20230703194346.jpg

Fourth Quarter and Full Year 2024 Results

Fourth quarter and full year 2024 results were reviewed by management during a live audio webcast with the financial community on January 30, 2025. The presentation was followed by a Q&A session.  

Upcoming Events

25Mar

2025

BNP Paribas Exane Healthcare Conference

08:00 Virtual

Broker Conference


26Mar

2025

Goldman Sachs Innovation Clinic Event

08:00 - 15:00 GMT (London)

Broker Conference


24Apr

2025

First Quarter 2025

First quarter 2025 results will be reviewed by management during a live audio webcast with the financial community on April 24, 2025. The presentation will be followed by a Q&A session.

13:00 - 14:30 CET (7:00am – 8:30am EDT)

Quarterly Results


Press Releases


March 20, 2025
Press Release: Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline

March 8, 2025
Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD

March 5, 2025
Press release: Sanofi successfully prices EUR 1.5 billion of bond issue

Dr. Lingaraju checks the health of Manikantan as his sister Geetha watches closely inside the Billigiri Ranganathaswamy Temple Tiger Reserve in Chamrajanagara district, Karnataka state, India

Environment, Social, Governance

As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.

Karine Roblot, wearing a light green protective suit, operating steel equipment with lots of valves, gauges and tubing
Karine Roblot, Vaccine Formulation Technician, Val de Reuil, France

2024 20-F

Presenting our 2024 FORM 20-F.

Subscribe to investor email alerts

Sign up to receive email alerts for various types of investor content

Contact Our Investor Relations Team

To join the Sanofi front desk,

Please contact the Global Headquarters in France :
+33 (0)1 53 77 40 00

To contact the Investor Relations team:

46 avenue de la Grande Armée
75017 Paris FRANCE
investor.relations (at) sanofi.com